Recombinant Cytotoxins Specific for Cancer Cells
- 1 December 1999
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 886 (1) , 297-299
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13International Journal of Cancer, 1998
- Novel anti–brain tumor cytotoxins specific for cancer cellsNature Biotechnology, 1998
- Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumorsNature Medicine, 1997
- The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptorThe Journal of Immunology, 1997
- Receptor for Interleukin (IL) 13 Does Not Interact with IL4 but Receptor for IL4 Interacts with IL13 on Human Glioma CellsJournal of Biological Chemistry, 1996
- Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxinNature Medicine, 1996
- A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin Is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4Journal of Biological Chemistry, 1995
- Receptors for interleukin‐13 and interleukin‐4 are complex and share a novel component that functions in signal transduction.The EMBO Journal, 1993
- Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.Proceedings of the National Academy of Sciences, 1993
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993